Company profile for Century Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Century Therapeutics is an innovative biotechnology company that is building an industry leading allogeneic iPSC-derived cell therapy platform that integrates cutting-edge gene editing, protein engineering, technical development, and manufacturing capabilities to generate allogeneic, iPSC-derived NK and T cell therapies for both hematological and solid tumor malignancies with significant unmet medical need.Our genetically-engi...
Century Therapeutics is an innovative biotechnology company that is building an industry leading allogeneic iPSC-derived cell therapy platform that integrates cutting-edge gene editing, protein engineering, technical development, and manufacturing capabilities to generate allogeneic, iPSC-derived NK and T cell therapies for both hematological and solid tumor malignancies with significant unmet medical need.Our genetically-engineered, universal iPSCs-derived immune effector cell products (NK, T, Dendritic cells, and macrophage) are designed to specifically target hematologic and solid tumor cancers. ]

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3675 Market Street Philadelphia, PA 19104
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/09/3202269/0/en/Century-Therapeutics-Appoints-Accomplished-Biotechnology-Leaders-Dr-Han-Lee-and-Dr-Martin-Murphy-to-Board-of-Directors.html

GLOBENEWSWIRE
09 Dec 2025

https://www.globenewswire.com/news-release/2025/11/25/3194701/0/en/Century-Therapeutics-to-Participate-in-Piper-Sandler-37th-Annual-Healthcare-Conference.html

GLOBENEWSWIRE
25 Nov 2025

https://www.fiercebiotech.com/biotech/century-candel-and-macrogenics-call-time-certain-clinical-trials-conserve-cash

FIERCE BIOTECH
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187138/0/en/Century-Therapeutics-Announces-New-Beta-Islet-Program-for-Type-1-Diabetes.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187204/0/en/Century-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/10/14/3166629/0/en/Century-Therapeutics-to-Present-at-Chardan-s-9th-Annual-Genetic-Medicines-Conference.html

GLOBENEWSWIRE
14 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty